Cargando…

A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes

AIM: To construct a simple screening tool for predicting diabetic kidney disease in Chinese patients with type 2 diabetes. MATERIALS AND METHODS: In the development cohort, the clinical and procedural characteristics of the 4,795 patients were considered as candidate univariate predictors of diabeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Mian, Lu, Junxi, Zhang, Lei, Liu, Fengjing, Chen, Si, Han, Ying, Zhao, Fangya, Guo, Kaifeng, Bao, Yuqian, Chen, Haibing, Jia, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731980/
https://www.ncbi.nlm.nih.gov/pubmed/29254270
http://dx.doi.org/10.18632/oncotarget.21684
_version_ 1783286605235093504
author Wu, Mian
Lu, Junxi
Zhang, Lei
Liu, Fengjing
Chen, Si
Han, Ying
Zhao, Fangya
Guo, Kaifeng
Bao, Yuqian
Chen, Haibing
Jia, Weiping
author_facet Wu, Mian
Lu, Junxi
Zhang, Lei
Liu, Fengjing
Chen, Si
Han, Ying
Zhao, Fangya
Guo, Kaifeng
Bao, Yuqian
Chen, Haibing
Jia, Weiping
author_sort Wu, Mian
collection PubMed
description AIM: To construct a simple screening tool for predicting diabetic kidney disease in Chinese patients with type 2 diabetes. MATERIALS AND METHODS: In the development cohort, the clinical and procedural characteristics of the 4,795 patients were considered as candidate univariate predictors of diabetic kidney disease. The β-coefficients derived from a multiple logistic regression model predicting the presence of DKD were used to calculate the risk score. The performance of the risk score was validated in a cross-sectional and a prospective cohort population. RESULTS: The risk score included sex, body mass index, systolic blood pressure, and duration of diabetes. The total point ranged from 0 to 39. In the development cohort, compared with participants with risk score < 10, those with risk score between 10 to 20, 21 to 30, and > 30 had ORs of 3.21, 7.92 and 17.55 for developing diabetic kidney disease, respectively. In the prospective cohort, 60.9% patients with risk score over 30 were expected to develop DKD at 72 months of follow-up. CONCLUSIONS: Sex, body mass index, systolic blood pressure, and duration of diabetes were independent predictors of diabetic kidney disease, and the derived risk equation was a simple screening tool for screening diabetic kidney disease in Chinese patients with type 2 diabetes.
format Online
Article
Text
id pubmed-5731980
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57319802017-12-17 A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes Wu, Mian Lu, Junxi Zhang, Lei Liu, Fengjing Chen, Si Han, Ying Zhao, Fangya Guo, Kaifeng Bao, Yuqian Chen, Haibing Jia, Weiping Oncotarget Clinical Research Paper AIM: To construct a simple screening tool for predicting diabetic kidney disease in Chinese patients with type 2 diabetes. MATERIALS AND METHODS: In the development cohort, the clinical and procedural characteristics of the 4,795 patients were considered as candidate univariate predictors of diabetic kidney disease. The β-coefficients derived from a multiple logistic regression model predicting the presence of DKD were used to calculate the risk score. The performance of the risk score was validated in a cross-sectional and a prospective cohort population. RESULTS: The risk score included sex, body mass index, systolic blood pressure, and duration of diabetes. The total point ranged from 0 to 39. In the development cohort, compared with participants with risk score < 10, those with risk score between 10 to 20, 21 to 30, and > 30 had ORs of 3.21, 7.92 and 17.55 for developing diabetic kidney disease, respectively. In the prospective cohort, 60.9% patients with risk score over 30 were expected to develop DKD at 72 months of follow-up. CONCLUSIONS: Sex, body mass index, systolic blood pressure, and duration of diabetes were independent predictors of diabetic kidney disease, and the derived risk equation was a simple screening tool for screening diabetic kidney disease in Chinese patients with type 2 diabetes. Impact Journals LLC 2017-10-09 /pmc/articles/PMC5731980/ /pubmed/29254270 http://dx.doi.org/10.18632/oncotarget.21684 Text en Copyright: © 2017 Wu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Clinical Research Paper
Wu, Mian
Lu, Junxi
Zhang, Lei
Liu, Fengjing
Chen, Si
Han, Ying
Zhao, Fangya
Guo, Kaifeng
Bao, Yuqian
Chen, Haibing
Jia, Weiping
A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes
title A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes
title_full A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes
title_fullStr A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes
title_full_unstemmed A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes
title_short A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes
title_sort non-laboratory-based risk score for predicting diabetic kidney disease in chinese patients with type 2 diabetes
topic Clinical Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731980/
https://www.ncbi.nlm.nih.gov/pubmed/29254270
http://dx.doi.org/10.18632/oncotarget.21684
work_keys_str_mv AT wumian anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT lujunxi anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT zhanglei anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT liufengjing anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT chensi anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT hanying anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT zhaofangya anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT guokaifeng anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT baoyuqian anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT chenhaibing anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT jiaweiping anonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT wumian nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT lujunxi nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT zhanglei nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT liufengjing nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT chensi nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT hanying nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT zhaofangya nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT guokaifeng nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT baoyuqian nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT chenhaibing nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes
AT jiaweiping nonlaboratorybasedriskscoreforpredictingdiabetickidneydiseaseinchinesepatientswithtype2diabetes